1 |
CROSBIE E J, KITSON S J, MCALPINE J N, et al. Endometrial cancer[J]. Lancet, 2022, 399( 10333): 1412- 1428.
|
2 |
MITRIC C, BERNARDINI M Q. Endometrial Cancer: Transitioning from Histology to Genomics[J]. Curr Oncol, 2022, 29( 2): 741- 757.
|
3 |
HARKENRIDER M M, ABU-RUSTUM N, ALBUQUERQUE K, et al. Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline[J]. Pract Radiat Oncol, 2023, 13( 1): 41- 65.
|
4 |
MAHDI H, CHELARIU-RAICU A, SLOMOVITZ B M. Immunotherapy in endometrial cancer[J]. Int J Gynecol Cancer, 2023, 33( 3): 351- 357.
|
5 |
LEFEBVRE T L, UENO Y, DOHAN A, et al. Development and Validation of Multiparametric MRI-based Radiomics Models for Preoperative Risk Stratification of Endometrial Cancer[J]. Radiology, 2022, 305( 2): 375- 386.
|
6 |
KELES D K, EVRIMLER S, MERD N, et al. Endometrial cancer: the role of MRI quantitative assessment in preoperative staging and risk stratification[J]. Acta Radiol, 2022, 63( 8): 1126- 1133.
|
7 |
MAHESHWARI E, NOUGARET S, STEIN E B, et al. Update on MRI in Evaluation and Treatment of Endometrial Cancer[J]. Radiographics, 2022, 42( 7): 2112- 2130.
|
8 |
FASMER K E, HODNELAND E, DYBVIK J A, et al. Whole-Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial Cancer[J]. J Magn Reson Imaging, 2021, 53( 3): 928- 937.
|
9 |
中国抗癌协会妇科肿瘤专业委员会. 子宫内膜癌诊断与治疗指南(2021年版)[J]. 中国癌症杂志, 2021, 31( 6): 501- 512.
|
10 |
KASIUS J C, PIJNENBORG J M A, LINDEMANN K, et al. Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification[J]. Cancers (Basel), 2021, 13( 22): 5848.
|
11 |
NEES L K, HEUBLEIN S, STEINMACHER S, et al. Endometrial hyperplasia as a risk factor of endometrial cancer[J]. Arch Gynecol Obstet, 2022, 306( 2): 407- 421.
|
12 |
KAKO T D, KAMAL M Z, DHOLAKIA J, et al. High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile[J]. Int J Clin Oncol, 2022, 27( 2): 323- 331.
|
13 |
王赛凤, 史蔚, 谢咸晶. RNA结合基序5基因敲除子宫内膜癌细胞系及其作用研究[J]. 实用医学杂志, 2022, 38( 10): 1203- 1207.
|
14 |
李松, 董莉丽, 孙丽, 等. 微小RNA-191通过靶向调节TET1影响子宫内膜癌细胞的增殖和侵袭[J]. 实用医学杂志, 2021, 37( 8): 1014- 1018.
|
15 |
ESKANDER R N, SILL M W, BEFFA L, et al. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer[J]. N Engl J Med, 2023, 388( 23): 2159- 2170.
|
16 |
MAHDI H, CHELARIU-RAICU A, SLOMOVITZ B M. Immunotherapy in endometrial cancer[J]. Int J Gynecol Cancer, 2023, 33( 3): 351- 357.
|
17 |
BEREK J S, MATIAS-GUIU X, CREUTZBERG C, et al. FIGO staging of endometrial cancer: 2023[J]. Int J Gynaecol Obstet, 2023, 162( 2): 383- 394.
|
18 |
HARKENRIDER M M, ABU-RUSTUM N, ALBUQUERQUE K, et al. Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline[J]. Pract Radiat Oncol, 2023, 13( 1): 41- 65.
|
19 |
任杰, 金延方, 崔婷婷, 等. MRI对子宫内膜癌组织学分级的价值研究[J]. 肿瘤代谢与营养电子杂志, 2022, 9( 1): 84- 88.
|
20 |
MA X, REN X, MA F, et al. Volumetric apparent diffusion coefficient (ADC) histogram metrics as imaging biomarkers for pretreatment predicting response to fertility-sparing treatment in patients with endometrial cancer[J]. Gynecol Oncol, 2022, 165( 3): 594- 602.
|
21 |
KAKKAR C, GUPTA K, JAIN K, et al. Diagnostic Accuracy of Calculated Tumor Volumes and Apparent Diffusion Coefficient Values in Predicting Endometrial Cancer Grade[J]. Int J Appl Basic Med Res, 2022, 12( 1): 37- 42.
|
22 |
MORI T, KATO H, KAWAGUCHI M, et al. A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma[J]. Eur Radiol, 2022, 32( 6): 4128- 4136.
|
23 |
BI Q, CHEN Y, CHEN J, et al. Predictive value of T2-weighted imaging and dynamic contrast-enhanced MRI for assessing cervical invasion in patients with endometrial cancer: a meta-analysis[J]. Clin Imaging, 2021, 78( 1): 206- 213.
|
24 |
TANG W, CHEN L, JIN Z, et al. The diagnostic dilemma with the plateau pattern of the time-intensity curve: can the relative apparent diffusion coefficient (rADC) optimise the ADC parameter for differentiating breast lesions?[J] Clin Radiol, 2021, 76( 9): 688- 695.
|
25 |
FENG A, YUAN P, HUANG T, et al. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI[J]. Acad Radiol, 2022, 29( 9): 1320- 1331.
|